These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 29171987)
1. Dysregulation of miR-126/Crk protein axis predicts poor prognosis in gastric cancer patients. Feng R; Sah BK; Beeharry MK; Yuan F; Su L; Jin X; Yan M; Liu B; Li C; Zhu Z Cancer Biomark; 2018 Feb; 21(2):335-343. PubMed ID: 29171987 [TBL] [Abstract][Full Text] [Related]
2. miR-126: An indicator of poor prognosis and recurrence in histologically lymph node-negative gastric cancer. Feng R; Sah BK; Li J; Lu S; Yuan F; Jin X; Yan M; Liu B; Li C; Zhu Z Cancer Biomark; 2018; 23(3):437-445. PubMed ID: 30248047 [TBL] [Abstract][Full Text] [Related]
3. Down-regulated serum miR-126 is associated with aggressive progression and poor prognosis of gastric cancer. Feng R; Beeharry MK; Lu S; Sah BK; Yuan F; Yan M; Liu B; Li C; Zhu Z Cancer Biomark; 2018; 22(1):119-126. PubMed ID: 29562500 [TBL] [Abstract][Full Text] [Related]
4. MiR-126 inhibits the invasion of gastric cancer cell in part by targeting Crk. Li X; Wang F; Qi Y Eur Rev Med Pharmacol Sci; 2014; 18(14):2031-7. PubMed ID: 25027343 [TBL] [Abstract][Full Text] [Related]
5. miR-126 functions as a tumour suppressor in human gastric cancer. Feng R; Chen X; Yu Y; Su L; Yu B; Li J; Cai Q; Yan M; Liu B; Zhu Z Cancer Lett; 2010 Dec; 298(1):50-63. PubMed ID: 20619534 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of combined microRNA-206 and CyclinD2 in gastric cancer patients after curative surgery: A retrospective cohort study. Shi H; Han J; Yue S; Zhang T; Zhu W; Zhang D Biomed Pharmacother; 2015 Apr; 71():210-5. PubMed ID: 25960238 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer. Kong Y; Ning L; Qiu F; Yu Q; Cao B Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of tissue miR-338-3p predicts unfavorable prognosis of gastric cancer. Liu S; Suo J; Wang C; Sun X; Wang D; He L; Zhang Y; Li W Cancer Biomark; 2017 Dec; 21(1):117-122. PubMed ID: 29060930 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of miR-552 Predicts Unfavorable Prognosis of Gastric Cancer and Promotes the Proliferation, Migration, and Invasion of Gastric Cancer Cells. Feng X; Zhu M; Liao B; Tian T; Li M; Wang Z; Chen G Oncol Res Treat; 2020; 43(3):103-111. PubMed ID: 31958799 [TBL] [Abstract][Full Text] [Related]
10. Decreased miR-198 expression and its prognostic significance in human gastric cancer. Cui Z; Zheng X; Kong D World J Surg Oncol; 2016 Feb; 14():33. PubMed ID: 26852230 [TBL] [Abstract][Full Text] [Related]
11. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer. Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of microRNA-23a/b promotes tumor progression and confers poor prognosis in patients with gastric cancer. Ma G; Dai W; Sang A; Yang X; Gao C Int J Clin Exp Pathol; 2014; 7(12):8833-40. PubMed ID: 25674252 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of microRNA-126 and CRK expression in gastric cancer. Yue S; Shi H; Han J; Zhang T; Zhu W; Zhang D Onco Targets Ther; 2016; 9():6127-6135. PubMed ID: 27785060 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of miR-145-5p correlates with poor prognosis in gastric cancer. Zhang Y; Wen X; Hu XL; Cheng LZ; Yu JY; Wei ZB Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3026-30. PubMed ID: 27460730 [TBL] [Abstract][Full Text] [Related]
15. Expression of miR-1294 is downregulated and predicts a poor prognosis in gastric cancer. Shi YX; Ye BL; Hu BR; Ruan XJ Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5525-5530. PubMed ID: 30229824 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer. Xu M; Qin S; Cao F; Ding S; Li M Int J Oncol; 2017 Sep; 51(3):867-876. PubMed ID: 28713929 [TBL] [Abstract][Full Text] [Related]
17. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1. Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895 [TBL] [Abstract][Full Text] [Related]
18. Prognostic Implications of miR-302a/b/c/d in Human Gastric Cancer. Ma G; Li Q; Dai W; Yang X; Sang A Pathol Oncol Res; 2017 Oct; 23(4):899-905. PubMed ID: 28795345 [TBL] [Abstract][Full Text] [Related]
19. Tumor Expression of Obermannova R; Redova-Lojova M; Vychytilova-Faltejskova P; Grell P; Cho WC; Sachlova M; Svoboda M; Vyzula R; Slaby O Anticancer Res; 2018 Jun; 38(6):3719-3724. PubMed ID: 29848733 [TBL] [Abstract][Full Text] [Related]
20. High expression of miR-16 and miR-451 predicating better prognosis in patients with gastric cancer. Ren C; Chen H; Han C; Fu D; Wang D; Shen M J Cancer Res Clin Oncol; 2016 Dec; 142(12):2489-2496. PubMed ID: 27605261 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]